Literature DB >> 26988674

[Chinese expert consensus on the diagnosis and management of acute pulmonary embolism (2015)].

.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26988674     DOI： 10.3760/cma.j.issn.0253-3758.2016.03.005

Source DB:  PubMed          Journal:  Zhonghua Xin Xue Guan Bing Za Zhi        ISSN： 0253-3758


× No keyword cloud information.
  6 in total

1.  Changes of serum P62 and Beclin 1 in patients with pulmonary embolism during treatment and their predictive value for efficacy.

Authors:  Xuehui Zhang; Liu Huang; Lijiang Shao; Xuxia Chen; Jinguo Chu; Xueqin Chen
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

2.  Risk Assessment in Chinese Hospitalized Patients Comparing the Padua and Caprini Scoring Algorithms.

Authors:  Xiaolan Chen; Lei Pan; Hui Deng; Jingyuan Zhang; Xinjie Tong; He Huang; Min Zhang; Jianlin He; Joseph A Caprini; Yong Wang
Journal:  Clin Appl Thromb Hemost       Date:  2018-09-09       Impact factor: 2.389

3.  Catheter Directed Thrombolysis in the Treatment of Acute Pulmonary Embolism: Early Hemodynamic Recovery and Improvement in Prognosis.

Authors:  Qinglong Guan; Xiaofei Wang; Chenglong Liu; Yuan Gao; Haibo Chen; Gang Li
Journal:  Biomed Res Int       Date:  2022-03-24       Impact factor: 3.411

4.  Case Report: Cardiac Multiple Thrombus and Pulmonary Embolism Associated With Mycoplasma Pneumonia Infection in a Child.

Authors:  Tongqiang Zhang; Jiafeng Zheng; Hongbo Wang; Yongsheng Xu; Jing Ning; Chunquan Cai
Journal:  Front Pediatr       Date:  2022-07-18       Impact factor: 3.569

5.  Joint analysis of D-dimer, N-terminal pro b-type natriuretic peptide, and cardiac troponin I on predicting acute pulmonary embolism relapse and mortality.

Authors:  Xiaoyu Liu; Liying Zheng; Jing Han; Lu Song; Hemei Geng; Yunqiu Liu
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

6.  Comparison of urokinase and reteplase thrombolytic treatment in patients with high-risk pulmonary embolism.

Authors:  Yi Zhang; Lan Ma; Qi Fu; Tao Zhao; Rui-Ying Yan; Xing Su
Journal:  Exp Ther Med       Date:  2019-10-31       Impact factor: 2.447
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.